 All right we've reached the point of the Meeting where it's time for the council initiated discussion and Again, I think you know the drill here. We've been in charge of the agenda up until now And this is your opportunity to raise issues with us bring issues to our attention or maybe Plant the idea of reports or information you'd like us to bring back to you at a future council meeting floors open Remember one thing from the last one was a Presentation on the R01 portfolio just to put that in the text or anything else So that was was one of Jeff's slides went through pretty quickly I Don't know if you were looking for something more comprehensive than that Yeah, there were there were a lot of slides there, D. I think yes, you were looking for something more than that Missed it somehow. I mean I saw where it was broken down like how things were categorized and that included our ones and everything, but I Jeff you want to come to a microphone, but was the unsolicited he had a couple of slides about unsolicited I mean that's that's synonymous with R01 pull Well, I think what we what we remembered was wanting you wanting to get some understanding of how it distributed across the Domains, but maybe there was something more subtle that you were looking for Or more detailed when I go back and look at what's there Any things you For future open session presentations You know we have our list of things that we think you might want to hear about other people other topics at NIH Are there any things that you're curious and I can't make any promises because it's always gonna see what the health packed in this September Council schedule is but either September February. Yeah Two things that are very unlinked One is the an update from Jeff or someone on What are what is the technology development that is happening that is needed? you know a kind of a state of the art in terms of the genomic technology aspects and then a Second that's very related. We have you have a new director of the Genomes and Society or whatever the division very important. Yeah That we really haven't heard. Yeah, what his vision is We were planning for that for September remember that we sort of have that pencil then I think Larry thinks that's the case to Larry Are you back? Yes Larry September? We had said right? Something like that. Yeah. Yeah. Oh Yes, true. Yeah. Good point. So it's September We're gonna have a report from the Genomic Society working group. So that we maybe we will couple that with Larry Presenting some things and so you can hear from him and get a chance to talk to him or I think we'd even kicked around the idea of maybe a research Presentation from an LC investigator So you by the way, you're just trying to make up for your anti-LC comment before as you're asking Yeah, I was hoping you'd have it after September because I go up council I Been really excited to hear about all of the different initiatives Across the board and I just wondered if there were if it would be possible to get from each one of those initiatives an example of Where the sequencing or the technology has made a difference in a clinical outcome Me like me like a couple of examples. I mean, I'm just I've heard about Caesar I've heard about ignite heard about a merge and I'm just wondering sort of What the examples are? You know about a like a case study What it would look like but that sounds right. Yeah, okay And Howard were you talking technology? Were you talking about sequencing technology or broader? Well? I was I Was thinking sequencing technology, but I didn't say it that way because there might be some amazing things that they're coming down That I just don't know about the the you know, what's next for the $1,000 genome committee I mean is it is it down to go down to a hundred or is it do more for a thousand or The discussion in the last council about the need for more functional assays And so that would be something that would feed into the whole technology part as well Yeah, I was leaving it to Jeff or whoever the is lead technocrat, but All right, anything else Well, you know where to find us if something occurs to you All right, just a couple more things for the open session then Item of interest we have three reports from our liaison societies ASHG genetic Alliance and Society of Genetic Counselors These are lists of recent activities and items of interest from those societies They're attached to the open session agenda and they're in the ECB if you want to look at those and At this point, I'm required to read the conflict of interest statement This applies to the applications that you will review in the closed session You must leave the meeting room when applications submitted by your own organization are being individually discussed in the case of state higher Education or other systems with multiple campuses geographically separated own Organization is intended to mean the entire system except where a determination has been made that the components are separate Organizations for the purpose of conflict of interest You should avoid situations that could give rise to charges of conflict of interest where whether real or apparent For example, you should not participate in the deliberations and actions on any application from or involving your spouse or child Or recent student recent teacher a professional collaborator with whom you have worked closely a close personal friend or scientist with whom you've had Longstanding scientific or personal differences The NHGRI staff will determine the appropriate action based on recency frequency and strengths of such associations or interests Either positive or negative and will instruct you accordingly in Council actions in which you vote on a block of applications without discussing any individual one the on-block action Your vote will not apply to any application from an institution fulfilling the criteria noted above In your folders, there should be a hard copy COI form Please sign it and we'll collect it from you at some point and with that the open session is ended and you can gavel us to close Thank you everyone. So we'll give the IT staff a chance to take down the cameras And we'll reconvene in closed session in about 10 or 15 minutes. So don't go far